Urologists

29-1229.03
Median wage $265,930/yr342,720 employed (US)Rank #826 of 923 scored · top 89% by substitution

Diagnose, treat, and help prevent benign and malignant medical and surgical disorders of the genitourinary system and the renal glands.

Sub-scores

0–100 · band = confidence interval from rater disagreement

Substitution14
Exposure15
Augmentation58

Substitution — the headline: capability discounted by cost, barriers and adoption.

Exposure — technical capability alone, regardless of whether anyone deploys it.

Augmentation — how much AI assists without replacing. High here + moderate substitution = a changing job, not a disappearing one.

Tasks on the substitution scale

14 rated tasks, binned by substitution score.

Position among all scored occupations

Distribution of 923 occupation scores; the marker is this occupation.

Tasks with substitution ≥ 70

0%

Run 1.0.0-draft.1 · computed 2026-08-05 · rater panel: claude-sonnet-5, claude-haiku-4-5-20251001 · intervals span rater disagreement.

Why this score

The five weighted dimensions of the composite, averaged across this occupation's tasks (importance-weighted, panel mean). Exact weights and formulas: /api/v1/methodology.

Task automatabilityw 35%13

panel mean rating 1.5/5 → substitution pressure 13/100

Technical feasibility todayw 20%19

panel mean rating 1.8/5 → substitution pressure 19/100

Cost vs. human wagew 15%13

panel mean rating 1.5/5 → substitution pressure 13/100

Adoption barriersw 20%inverted — strong barriers lower the score6

panel mean rating 4.7/5 (barrier strength) → substitution pressure 6/100

Sector adoption velocityw 10%23

panel mean rating 1.9/5 → substitution pressure 23/100

Task breakdown (14 tasks)

Substitution pressure per task, weighted by O*NET importance in the composite. Expand a task for the full rater audit trail — every rating, every model, every rationale.

Document or review patients' histories.

57

CI 45–70 · exposure 62 · augmentation 100 · importance 4.8/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510014/5Healthcare is a digitized, information-intensive sector with rapid AI adoption; clinical documentation and history review automation are among the most deployed AI use cases in hospitals and practices today.
Sector adoption velocityclaude-sonnet-53/5Healthcare has moderate AI adoption for documentation via ambient scribes and EHR copilots, with growing pilots but not yet universal deep integration compared to finance or tech sectors.
Augmentation potentialclaude-haiku-4-5-202510015/5AI documentation and history review tools substantially augment physician productivity by automating transcription, organizing prior records, and surfacing key clinical details, allowing urologists to focus on clinical decision-making while remaining in the loop.
Augmentation potentialclaude-sonnet-55/5AI documentation assistants substantially reduce time urologists spend writing and organizing patient histories, letting them focus on clinical review and patient interaction while staying in the loop.
Task automatabilityclaude-haiku-4-5-202510014/5AI can extract, summarize, and organize patient history information from clinical notes, EHR systems, and prior documentation with high accuracy, easily achieving 50% time savings on documentation and review tasks. However, complex clinical reasoning or judgments requiring specialist knowledge may still need physician oversight.
Task automatabilityclaude-sonnet-53/5AI can draft or summarize patient histories from intake forms, prior notes, or ambient dictation, saving significant documentation time, but review for accuracy and clinical relevance still requires physician judgment and verification.on.
Adoption barriersclaude-haiku-4-5-202510013/5Moderate barriers exist: physicians retain legal responsibility for accuracy and completeness of medical records, requiring human verification; HIPAA compliance and EHR integration requirements add friction, though these are now routine in most systems.
Adoption barriersclaude-sonnet-54/5Medical records require physician verification and legal accountability for accuracy; documentation errors carry liability risk, and regulations (HIPAA, medical board requirements) constrain fully autonomous AI documentation.
Cost vs. human wageclaude-haiku-4-5-202510014/5AI-powered documentation and review costs (inference, integration, oversight) are substantially cheaper than physician time spent on manual charting and history review; the per-task cost to a healthcare system is likely 10–50x lower than physician labor.
Cost vs. human wageclaude-sonnet-53/5AI scribe/summarization tools cost a fraction of physician time per note, but licensing fees, EHR integration, and mandatory physician review keep overall cost savings moderate rather than order-of-magnitude.
Technical feasibility todayclaude-haiku-4-5-202510014/5Deployed products (EHR-integrated AI scribes, clinical documentation assistants, and LLM-based summarization tools) are already in production in healthcare systems and reliably perform medical history extraction and review at scale with minimal errors on straightforward cases.
Technical feasibility todayclaude-sonnet-53/5Ambient clinical documentation tools (e.g., DAX Copilot, Nuance) and EHR-integrated summarization are deployed in production at many health systems, but accuracy issues and need for physician review limit full reliability.

Examine patients using equipment, such as radiograph (x-ray) machines or fluoroscopes, to determine the nature and extent of disorder or injury.

26

CI 20–32 · exposure 30 · augmentation 75 · importance 4.8/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510013/5Healthcare institutions are piloting AI-assisted radiology tools, but adoption remains primarily in large academic and hospital systems. Many smaller practices and clinics still rely on manual review, and displacement of radiologists is minimal—most deployments augment rather than replace.
Sector adoption velocityclaude-sonnet-52/5Healthcare, especially specialized surgical fields like urology, adopts AI diagnostic tools slowly due to regulatory approval processes, liability concerns, and integration into clinical workflows.
Augmentation potentialclaude-haiku-4-5-202510014/5AI significantly improves radiologist productivity by flagging potential abnormalities, reducing review time, and prioritizing high-risk cases. The human radiologist remains in the loop for final interpretation, making this a strong augmentation scenario with documented improvements in throughput and consistency.
Augmentation potentialclaude-sonnet-54/5AI-assisted image analysis (e.g., flagging abnormalities in x-rays or fluoroscopic images) can meaningfully speed up and improve diagnostic accuracy while the urologist remains the decision-maker.
Task automatabilityclaude-haiku-4-5-202510012/5While AI can assist in image analysis and interpretation of radiographs, the physical examination component (direct patient contact, palpation, clinical observation) cannot be automated. Human radiologists must still perform the imaging and make clinical judgments on complex cases, limiting time savings to roughly 20–30% in review workflows.
Task automatabilityclaude-sonnet-52/5Physical positioning, operation of imaging equipment, and real-time patient examination require hands-on physical presence and clinical judgment that current AI cannot replicate end-to-end; AI can assist with image interpretation but not the full examination process.
Adoption barriersclaude-haiku-4-5-202510014/5Medical imaging interpretation is licensed professional practice in most jurisdictions, and liability for diagnostic error falls on the credentialed physician. Regulatory bodies (FDA, medical boards) require human sign-off on clinical imaging reports, creating a hard legal barrier to full automation.
Adoption barriersclaude-sonnet-55/5Physically examining patients and making diagnostic determinations requires a licensed physician; legal, liability, and clinical standards mandate human involvement for this task.
Cost vs. human wageclaude-haiku-4-5-202510012/5AI inference for image analysis is cheap, but integrating it into clinical workflows, ensuring regulatory compliance, and maintaining radiologist oversight add significant costs. The all-in cost remains comparable to or higher than a radiologist's time on complex cases.
Cost vs. human wageclaude-sonnet-52/5AI diagnostic imaging tools add cost on top of required physician time and equipment; they don't yet replace the physician's examination, so overall cost savings are limited relative to full task substitution.
Technical feasibility todayclaude-haiku-4-5-202510013/5AI systems for radiology image classification and detection exist in production (e.g., fracture detection, stone identification), but they typically serve as assistive tools with material error rates on edge cases and require radiologist oversight. No fully autonomous diagnostic system reliably replaces radiologist judgment in clinical settings.
Technical feasibility todayclaude-sonnet-52/5AI imaging analysis products exist (e.g., for detecting lesions or stones) but they are narrow decision-support tools embedded within radiologist/urologist workflows, not autonomous examination systems performing the full task.

Order and interpret the results of diagnostic tests, such as prostate specific antigen (PSA) screening, to detect prostate cancer.

25

CI 20–30 · exposure 30 · augmentation 75 · importance 4.8/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510012/5Healthcare adoption of AI remains cautious and pilot-heavy in most regions; urologic practices have slower digitization than tech/finance sectors, and medico-legal risk aversion slows production deployment of autonomous test ordering and interpretation systems.
Sector adoption velocityclaude-sonnet-52/5Healthcare, especially specialist diagnostic decision-making, adopts AI slowly due to regulatory, liability, and workflow integration hurdles, with pilots more common than production deployment for this specific task.
Augmentation potentialclaude-haiku-4-5-202510014/5AI can substantially augment urologists by automatically flagging elevated PSA values, comparing to prior trends, and surfacing relevant guidelines—enabling faster, more thorough review while the physician retains clinical authority and final decision-making.
Augmentation potentialclaude-sonnet-54/5AI/ML risk calculators, imaging-assisted diagnostics, and decision-support tools meaningfully help urologists interpret PSA and related results faster and with better risk stratification, while the physician remains the decision-maker.
Task automatabilityclaude-haiku-4-5-202510012/5While AI can assist in PSA value analysis and flag abnormal results, the task requires clinical judgment about test ordering rationale, patient context, and interpretation in light of symptoms, family history, and risk factors. Current AI cannot reliably replace the full clinical decision-making loop end-to-end.
Task automatabilityclaude-sonnet-52/5Ordering tests is trivial administrative action, but interpreting PSA and related diagnostic results within clinical context requires integrating patient history, exam findings, and judgment that current AI cannot fully replicate end-to-end.
Adoption barriersclaude-haiku-4-5-202510014/5Urologists and physicians must legally order tests and sign off on clinical interpretations; liability for missed cancer diagnosis creates asymmetric error costs; regulatory frameworks (CLIA, state licensing) require licensed providers to take responsibility for test ordering and interpretation.
Adoption barriersclaude-sonnet-55/5Ordering and interpreting diagnostic tests for cancer screening is a licensed medical act with direct liability exposure; regulations and standard of care require a physician to authorize and interpret results.
Cost vs. human wageclaude-haiku-4-5-202510012/5AI inference is cheap, but integration into clinical workflows, regulatory compliance checks, and physician oversight add material cost; the all-in cost approaches or may exceed the cost of rapid clinician review for routine cases.
Cost vs. human wageclaude-sonnet-52/5Lab test processing is already automated and cheap, but the physician interpretation and clinical decision-making component still requires expensive specialist time with AI serving only as a support tool, not a full replacement, keeping blended cost comparable to human labor.
Technical feasibility todayclaude-haiku-4-5-202510013/5AI tools exist to assist with PSA result interpretation and flagging potential abnormalities, but deployed products remain narrow in scope and typically require physician review and final judgment; no mature system performs independent end-to-end ordering and interpretation at scale without oversight.
Technical feasibility todayclaude-sonnet-52/5AI-assisted interpretation tools (e.g., for imaging or biomarker risk stratification) exist but are adjunctive; no deployed product independently orders and interprets PSA results as a substitute for the urologist in production.

Teach or train medical and clinical staff.

19

CI 13–25 · exposure 17 · augmentation 63 · importance 4.3/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510012/5While some healthcare systems use AI to augment training materials or automate administrative scheduling of education, the actual teaching of clinical skills remains human-led. Adoption of AI for full training roles is nascent; most institutions still rely on urologists or senior staff as primary educators.
Sector adoption velocityclaude-sonnet-52/5Healthcare training adoption of AI is progressing slowly due to regulatory, liability, and hands-on skill requirements, lagging behind faster-adopting sectors like finance or software.
Augmentation potentialclaude-haiku-4-5-202510013/5AI can assist by generating case reviews, summarizing guidelines, creating practice questions, or scheduling sessions, modestly boosting instructor efficiency. However, AI does not meaningfully augment the core teaching task of explaining, demonstrating, assessing, and mentoring learners in real time.
Augmentation potentialclaude-sonnet-54/5AI can meaningfully assist by generating training materials, case studies, quizzes, and personalized learning content, freeing up physician time for hands-on instruction.
Task automatabilityclaude-haiku-4-5-202510011/5Teaching and training medical staff requires real-time interaction, feedback adaptation, assessment of individual learning needs, and mentorship—capabilities that demand human judgment and relationship-building. Current AI cannot replace the bidirectional dialogue, correction, and personalized instruction that effective clinical education demands.
Task automatabilityclaude-sonnet-52/5Training clinical staff involves live demonstration, hands-on supervision, and situational judgment that current AI cannot replicate end-to-end, though it can help generate materials or explanations.:
Adoption barriersclaude-haiku-4-5-202510014/5Medical education is heavily regulated by accreditation bodies (ACGME, specialty boards) and institutional credentialing, which legally require qualified physicians to certify clinical training. Liability and patient safety concerns create strong requirements that a licensed urologist personally oversee staff competency development.
Adoption barriersclaude-sonnet-54/5Clinical training often requires credentialed physician oversight and sign-off for competency verification, especially for procedural skills, creating strong professional and institutional barriers.
Cost vs. human wageclaude-haiku-4-5-202510011/5Deploying AI-generated training materials plus human oversight costs roughly the same or more than having an experienced urologist teach directly, especially when accounting for content quality assurance, learner assessment, and liability in clinical education.
Cost vs. human wageclaude-sonnet-52/5Creating training content with AI is cheap, but the bulk of value in this task comes from expert-led supervision and mentorship, which still requires paying the urologist's time.
Technical feasibility todayclaude-haiku-4-5-202510012/5While AI can generate educational content, Q&A modules, or lecture scripts, no deployed product reliably performs the full training task (delivery, assessment, feedback, skill verification) in clinical settings. Some institutions use AI-assisted content creation, but human instructors remain essential for actual teaching.
Technical feasibility todayclaude-sonnet-52/5AI tools exist for medical education content (case simulations, quizzes, explanatory text) but no deployed product independently trains urology staff in clinical/procedural skills at scale.

Prescribe medications to treat patients with erectile dysfunction (ED), infertility, or ejaculation problems.

16

CI 11–20 · exposure 20 · augmentation 63 · importance 4.5/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510012/5While urology practices use AI-assisted diagnostic and decision-support tools in some academic centers and larger practices, autonomous or near-autonomous prescription generation is not in production deployment. Adoption remains pilot-stage rather than broad clinical rollout.
Sector adoption velocityclaude-sonnet-52/5Healthcare, especially specialty prescribing, adopts AI slowly due to regulatory, liability, and EHR-integration frictions, with pilots more common than production deployment for autonomous prescribing decisions.
Augmentation potentialclaude-haiku-4-5-202510013/5AI can assist urologists by summarizing treatment guidelines, flagging drug interactions, and suggesting appropriate medications based on patient profiles, thereby improving prescription speed and reducing errors. However, the human physician must retain full clinical and legal responsibility for final selection and patient counseling.
Augmentation potentialclaude-sonnet-54/5AI can meaningfully assist urologists by summarizing patient history, suggesting evidence-based treatment options, and flagging drug interactions, improving decision speed and accuracy while the physician retains prescribing authority.
Task automatabilityclaude-haiku-4-5-202510012/5While AI can assist in treatment recommendations and drug selection based on clinical guidelines, the task requires real-time patient assessment, contraindication checking against full medical history, and individualized clinical judgment that current systems cannot fully replicate end-to-end. The prescription authority and legal responsibility remain non-delegable to AI alone.
Task automatabilityclaude-sonnet-52/5Prescribing requires clinical diagnosis, patient history review, physical exam findings, and legal authorization to write prescriptions; AI can suggest options but cannot independently perform or finalize this task today.
Adoption barriersclaude-haiku-4-5-202510015/5Prescription authority is legally restricted to licensed physicians in all jurisdictions; liability for adverse drug events falls on the prescriber, and patient-specific risk assessment requires licensed medical judgment. Regulatory bodies explicitly require human physician accountability for medication prescription.
Adoption barriersclaude-sonnet-55/5Prescribing medication is legally restricted to licensed physicians (or authorized prescribers), with strict regulatory, liability, and controlled-substance considerations preventing full automation.
Cost vs. human wageclaude-haiku-4-5-202510011/5The direct cost of AI-assisted decision support is low, but the task itself (prescription authority and patient interaction) cannot be substantially offloaded, so total labor substitution is minimal. Human physicians must remain in the loop, making the cost-saving advantage negligible.
Cost vs. human wageclaude-sonnet-52/5AI could cheaply generate suggested regimens, but the overall cost includes mandatory physician oversight, exam, and liability, keeping total cost close to or above the human-only pathway.
Technical feasibility todayclaude-haiku-4-5-202510012/5No deployed AI product independently prescribes medications in clinical practice; existing clinical decision support tools aid diagnosis and treatment suggestions but do not autonomously issue prescriptions. Regulatory and liability structures require a licensed physician to make and sign prescriptions.
Technical feasibility todayclaude-sonnet-51/5No deployed product independently prescribes medications for ED, infertility, or ejaculation issues in production; clinical decision support tools exist but do not autonomously execute prescribing.

Prescribe or administer antibiotics, antiseptics, or compresses to treat infection or injury.

10

CI 0–20 · exposure 13 · augmentation 63 · importance 4.8/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510011/5Medical prescribing and patient treatment remain heavily regulated and physician-led; adoption of AI in clinical decision-making is slow and cautious, with humans retaining final authority, especially in specialist urology.
Sector adoption velocityclaude-sonnet-52/5Healthcare, especially surgical specialties like urology, has been slower to adopt AI in direct clinical decision-making compared to administrative or information-based sectors.
Augmentation potentialclaude-haiku-4-5-202510013/5AI can assist by suggesting evidence-based antibiotic options based on infection type, patient allergies, and resistance patterns, helping physicians make faster, more informed decisions while the physician retains prescribing authority.
Augmentation potentialclaude-sonnet-54/5AI tools can meaningfully assist by suggesting evidence-based antibiotic choices, flagging drug interactions, and streamlining documentation, improving physician efficiency while the human retains control.
Task automatabilityclaude-haiku-4-5-202510011/5Prescribing medication requires clinical judgment about patient history, contraindications, and individual risk factors that current AI cannot reliably assess end-to-end. Administration of antibiotics and compresses involves direct patient contact and physical manipulation that AI systems cannot perform.
Task automatabilityclaude-sonnet-52/5Deciding on and prescribing antibiotics/antiseptics for a specific patient requires clinical judgment, exam findings, and diagnostic integration that current AI cannot reliably perform end-to-end without a physician.'
Adoption barriersclaude-haiku-4-5-202510015/5Prescribing controlled and regulated medications is legally restricted to licensed physicians in all jurisdictions; administering medical treatments to patients requires licensure and direct human accountability, creating hard regulatory barriers to any AI substitution.
Adoption barriersclaude-sonnet-55/5Prescribing medication is a licensed medical act requiring a physician's authorization, with significant liability and regulatory constraints preventing AI from independently performing this task.
Cost vs. human wageclaude-haiku-4-5-202510011/5AI systems have no cost advantage here since the task requires licensed physician involvement for legal and safety reasons; the human physician cost is unavoidable and typically cannot be offset by automation.
Cost vs. human wageclaude-sonnet-52/5AI decision-support software has low marginal cost, but the physician's time for exam, diagnosis, and legal prescribing authority remains necessary, keeping overall cost comparable to human-led care.
Technical feasibility todayclaude-haiku-4-5-202510011/5No deployed product can independently prescribe antibiotics or administer physical treatments; clinical decision-support systems exist but require physician sign-off and cannot autonomously make prescribing decisions in urology contexts.
Technical feasibility todayclaude-sonnet-52/5Clinical decision support tools can suggest antibiotic regimens based on guidelines, but no deployed product autonomously prescribes or administers treatment for urology patients in production.

Diagnose or treat diseases or disorders of genitourinary organs and tracts including erectile dysfunction (ED), infertility, incontinence, bladder cancer, prostate cancer, urethral stones, or premature ejaculation.

9

CI 3–16 · exposure 13 · augmentation 50 · importance 4.9/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510012/5Healthcare sectors show slower AI adoption in clinical decision-making compared to information/finance sectors. While imaging AI pilots are growing, deployment in actual diagnostic workflows remains limited, and most urologists still rely on traditional clinical methods.
Sector adoption velocityclaude-sonnet-52/5Medicine adopts AI cautiously and unevenly, with urology using some AI-assisted imaging or diagnostics but full clinical adoption remains slow due to regulation and safety concerns.
Augmentation potentialclaude-haiku-4-5-202510013/5AI can assist urologists by flagging abnormalities on imaging, suggesting differential diagnoses, and supporting literature search, but the clinician retains responsibility for examination, judgment, and treatment decisions. Meaningful but not transformative assistance.
Augmentation potentialclaude-sonnet-53/5AI can assist with imaging analysis, pathology review, risk stratification, and documentation, improving efficiency while the urologist retains diagnostic and treatment authority.
Task automatabilityclaude-haiku-4-5-202510012/5While AI can assist with image analysis (ultrasound, CT) and some diagnostic decision support, the task requires hands-on examination, complex clinical judgment integrating patient history with physical findings, and treatment decisions involving patient consultation. Current AI cannot perform the full diagnostic or treatment pathway end-to-end.
Task automatabilityclaude-sonnet-51/5Diagnosing and treating urological diseases requires physical examination, invasive procedures, surgery, and clinical judgment across diverse conditions that current AI cannot perform end-to-end.
Adoption barriersclaude-haiku-4-5-202510015/5Medical diagnosis and treatment of disease is legally restricted to licensed physicians; malpractice liability is high; regulatory oversight (FDA, state medical boards) covers urology practice; patient contact and informed consent are legal requirements. These create hard barriers to full substitution.
Adoption barriersclaude-sonnet-55/5Diagnosis and treatment of disease, including surgery and prescribing, legally require a licensed physician, creating hard regulatory and liability barriers.
Cost vs. human wageclaude-haiku-4-5-202510011/5AI inference for imaging analysis is cheap, but the total cost of integration, clinical validation, liability oversight, and the fact that human urologists remain essential for examination, counseling, and complex decision-making means AI is not cheaper than the full human service.
Cost vs. human wageclaude-sonnet-51/5AI cannot substitute for a urologist's clinical and procedural work, so there is no viable AI cost comparison for the full task.
Technical feasibility todayclaude-haiku-4-5-202510012/5Deployed AI products exist for narrow subtasks (e.g., prostate cancer detection in imaging), but no production system reliably performs the complete diagnosis or treatment of genitourinary disorders. Products show material error rates and narrow scope relative to the full clinical task.
Technical feasibility todayclaude-sonnet-51/5No deployed AI product independently diagnoses or treats genitourinary disorders; AI tools exist only as narrow decision-support or imaging aids used by physicians.

Refer patients to specialists when condition exceeds experience, expertise, or scope of practice.

8

CI 5–11 · exposure 9 · augmentation 50 · importance 4.3/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510011/5Specialty referral remains a core physician responsibility in all healthcare systems; there is negligible adoption of AI making autonomous referral decisions in production urology practices.
Sector adoption velocityclaude-sonnet-52/5Healthcare, especially clinical decision-making in specialty medicine, adopts AI slowly due to regulatory, liability, and safety concerns despite growing use of clinical decision support tools.
Augmentation potentialclaude-haiku-4-5-202510013/5AI can provide useful assistance by surfacing relevant specialist information, condition databases, and referral pathways, helping the urologist make better-informed decisions while they retain full authority and accountability.
Augmentation potentialclaude-sonnet-53/5AI can help by flagging complex cases, summarizing patient history, and suggesting relevant specialists, but the referral judgment itself remains physician-driven.
Task automatabilityclaude-haiku-4-5-202510011/5Referral decisions require nuanced clinical judgment about a patient's condition, the urologist's expertise boundaries, and appropriate specialist matching—contextual reasoning that current AI cannot reliably perform end-to-end without substantial human oversight that negates time savings.
Task automatabilityclaude-sonnet-51/5This requires clinical judgment about the limits of one's own expertise and a specific patient's complex case, combined with legal accountability for the referral decision; no AI system can autonomously perform this end-to-end today.
Adoption barriersclaude-haiku-4-5-202510015/5A licensed urologist must legally assess their own scope and make or authorize specialist referral decisions; liability, regulatory requirements, and professional accountability are hard barriers to substitution.
Adoption barriersclaude-sonnet-55/5Referral decisions are a core licensed medical judgment with direct liability implications; only a licensed physician can legally make and be accountable for this determination.
Cost vs. human wageclaude-haiku-4-5-202510011/5Referral decisions are a small fraction of billable clinical work and require a licensed physician's accountability; the cost of AI system setup and oversight would exceed the minimal time savings on this specific task.
Cost vs. human wageclaude-sonnet-52/5A physician must still review the case and authorize referral regardless of AI assistance, so cost savings are limited to minor administrative streamlining rather than replacing the decision-making cost.
Technical feasibility todayclaude-haiku-4-5-202510012/5While AI can assist in identifying specialist types from medical literature or condition databases, no deployed product reliably makes autonomous referral decisions in clinical practice; this remains a human physician judgment task in all production settings.
Technical feasibility todayclaude-sonnet-52/5Clinical decision support tools can flag red-flag symptoms or suggest specialist consults, but no deployed product independently makes or executes referral decisions in production without physician oversight.

Treat urologic disorders using alternatives to traditional surgery such as extracorporeal shock wave lithotripsy, laparoscopy, or laser techniques.

5

CI 3–7 · exposure 5 · augmentation 50 · importance 4.7/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510012/5While some hospitals adopt robotic-assisted surgical systems as tools under surgeon control, autonomous or AI-driven surgical intervention in urology remains pilot-stage and is not displacing surgeon labor. Adoption of AI-assisted guidance is slow and cautious given liability and regulatory constraints.
Sector adoption velocityclaude-sonnet-52/5While surgical robotics (e.g., da Vinci) are adopted in some contexts, they are tools operated by surgeons rather than autonomous AI, and healthcare procedural automation adoption remains slow and heavily regulated.
Augmentation potentialclaude-haiku-4-5-202510013/5AI can assist urologists through pre-operative imaging analysis, intra-operative guidance overlays, and post-operative outcome prediction, improving decision-making and precision. However, the surgeon remains essential and in control throughout the procedure, with AI playing a supportive role.
Augmentation potentialclaude-sonnet-53/5AI and robotic-assisted systems can enhance precision, imaging guidance, and pre-procedure planning, providing meaningful assistance while the urologist remains the primary operator.
Task automatabilityclaude-haiku-4-5-202510011/5This task requires real-time procedural decision-making, manual dexterity, and immediate response to patient anatomy during minimally invasive surgery. Current AI cannot perform these interventions end-to-end; AI has no demonstrated capacity to autonomously operate surgical equipment or adapt to live anatomical variation.
Task automatabilityclaude-sonnet-51/5This involves hands-on performance of minimally invasive urologic procedures requiring physical dexterity, real-time judgment, and manipulation of surgical equipment inside a patient's body—far beyond current AI capability.
Adoption barriersclaude-haiku-4-5-202510015/5Performing surgical procedures is strictly regulated; only licensed physicians (MDs/DOs) with surgical credentials can legally perform these interventions. Liability, malpractice risk, and explicit legal/regulatory requirements that a credentialed surgeon must perform or directly supervise create hard barriers to full automation.
Adoption barriersclaude-sonnet-55/5Performing invasive medical procedures requires a licensed physician, strict regulatory oversight, and legal liability for surgical outcomes, making this among the most protected tasks.
Cost vs. human wageclaude-haiku-4-5-202510011/5The capital cost of surgical equipment (lasers, lithotripsy units, laparoscopic systems) and the specialized training required remains far more expensive than human urologist labor when integrated end-to-end. Inference costs for image guidance are negligible compared to the procedural equipment and surgeon salary.
Cost vs. human wageclaude-sonnet-51/5There is no AI substitute performing this physical procedure, so cost comparison favors the human urologist entirely; AI cannot replace the labor involved.
Technical feasibility todayclaude-haiku-4-5-202510012/5While AI-assisted surgical systems exist in research and limited deployment (e.g., robotic arms under surgeon control, image analysis support), no AI product performs these urologic procedures reliably without a licensed surgeon in active control. Deployed surgical robots still require a surgeon to operate them directly.
Technical feasibility todayclaude-sonnet-51/5No deployed AI product autonomously performs lithotripsy, laparoscopy, or laser urologic procedures; robotic-assisted surgery still requires a surgeon actively controlling the device.

Perform abdominal, pelvic, or retroperitoneal surgeries.

5

CI 3–7 · exposure 5 · augmentation 63 · importance 4.6/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510012/5Surgical robotics have been adopted in select high-resource hospitals over two decades, but remain a minority of procedures; adoption is constrained by cost, reimbursement friction, surgeon resistance, and the fundamental requirement for licensed surgical judgment and presence.
Sector adoption velocityclaude-sonnet-52/5Surgical specialties adopt robotic-assist and imaging AI tools gradually due to safety validation, training, and capital requirements, remaining far behind digital-native sectors.
Augmentation potentialclaude-haiku-4-5-202510013/5Surgical robots and computer-assisted guidance (imaging registration, real-time tracking) do assist surgeons by improving visualization and precision on parts of the procedure, but the surgeon remains the decision-maker and primary actor; augmentation is meaningful but does not transform the overall surgical workflow.
Augmentation potentialclaude-sonnet-54/5AI-enhanced imaging, surgical navigation, and robotic-assisted platforms meaningfully improve precision and outcomes while the surgeon remains fully in control of the procedure.
Task automatabilityclaude-haiku-4-5-202510011/5Surgical procedures require real-time physical manipulation, spatial reasoning in a living patient, and adaptive decision-making in response to anatomical variation and complications. Current AI cannot perform end-to-end surgery or achieve 50% time savings on the critical operative phases.
Task automatabilityclaude-sonnet-51/5Physical urologic surgery requires manual dexterity, real-time tissue manipulation, and split-second judgment that current AI cannot perform end-to-end; robotic systems are human-controlled tools, not autonomous surgeons.
Adoption barriersclaude-haiku-4-5-202510015/5Performing surgery is legally restricted to licensed physicians (MDs/DOs) who must be present and responsible for the outcome; liability, regulatory (FDA, state medical boards), and patient-contact requirements create hard barriers to substitution by AI systems.
Adoption barriersclaude-sonnet-55/5Surgery legally must be performed by a licensed physician; medical licensing, malpractice liability, and patient safety regulations create hard barriers against any non-human execution.
Cost vs. human wageclaude-haiku-4-5-202510011/5Surgical robot systems cost millions and require extensive training, support, and surgeon oversight; the integrated cost per procedure far exceeds the loaded cost of a surgical team performing the same work, especially considering high liability and complication costs.
Cost vs. human wageclaude-sonnet-51/5Surgical robotics and any AI-assisted tools add substantial capital and maintenance costs on top of surgeon fees, making AI far more expensive than baseline human-only surgery, not cheaper.
Technical feasibility todayclaude-haiku-4-5-202510012/5While surgical robots (da Vinci) exist in production, they are teleoperated tools requiring a surgeon in control; AI plays only a narrow supporting role in guidance and visualization, not independent task execution. No deployed AI system performs urological surgery autonomously or with meaningful reduction in surgeon involvement.
Technical feasibility todayclaude-sonnet-51/5No deployed product performs independent abdominal/pelvic/retroperitoneal surgery; surgical robots like da Vinci require a human surgeon operating controls at all times.

Perform brachytherapy, cryotherapy, high intensity focused ultrasound (HIFU), or photodynamic therapy to treat prostate or other cancers.

4

CI 0–7 · exposure 5 · augmentation 50 · importance 3.9/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510011/5Healthcare adoption of AI in clinical decision support is gradual, and adoption of AI in direct procedural delivery is minimal. Regulatory caution, malpractice liability concerns, and the requirement for physician credentialing and oversight severely constrain real-world deployment in cancer treatment.
Sector adoption velocityclaude-sonnet-52/5Surgical/interventional oncology is a physically-grounded specialty with slow AI adoption limited to planning and imaging support tools, not procedural execution.
Augmentation potentialclaude-haiku-4-5-202510013/5AI can assist urologists by enhancing preoperative imaging analysis, treatment planning, and real-time ultrasound guidance during procedures, which can improve precision and outcomes. However, augmentation is limited to supportive roles; the surgeon remains the decision-maker and executor.
Augmentation potentialclaude-sonnet-53/5AI-assisted imaging, treatment planning, dosimetry calculations, and robotic-guidance systems can meaningfully improve precision and planning efficiency even though the physician performs the procedure.
Task automatabilityclaude-haiku-4-5-202510011/5This task requires real-time surgical manipulation, precise anatomical positioning, and immediate intraoperative decision-making in a high-stakes clinical environment. Current AI systems cannot autonomously perform the physical interventions or make the nuanced clinical judgments required during these minimally invasive cancer treatments.
Task automatabilityclaude-sonnet-51/5This is a hands-on invasive surgical/interventional procedure requiring physical manipulation of instruments and real-time tactile and visual judgment inside a patient; no AI system can perform the physical act of the procedure today.
Adoption barriersclaude-haiku-4-5-202510015/5These are invasive medical procedures that require a licensed physician to perform and bear legal responsibility for patient outcomes. Regulatory agencies (FDA, state medical boards) mandate human physician control, and liability frameworks make autonomous or unsupervised AI deployment infeasible.
Adoption barriersclaude-sonnet-55/5Performing invasive cancer treatment procedures requires a licensed physician with surgical/interventional privileges, malpractice liability, and regulatory oversight — hard legal and safety barriers prevent automation.
Cost vs. human wageclaude-haiku-4-5-202510011/5The infrastructure, equipment, regulatory compliance, and human oversight required for any AI-assisted version of these interventions makes the total cost substantially higher than the procedure itself, which is already a specialized high-value service.
Cost vs. human wageclaude-sonnet-51/5There is no AI substitute performing the procedure, so cost comparison favors the human urologist entirely; any AI-assisted planning adds cost rather than replacing the surgeon's fee.
Technical feasibility todayclaude-haiku-4-5-202510012/5While AI-assisted imaging analysis and treatment planning exist in limited research settings, no deployed product reliably performs these interventional procedures end-to-end. AI can support planning phases but cannot execute the actual therapeutic delivery or respond to real-time complications.
Technical feasibility todayclaude-sonnet-51/5No deployed product autonomously performs brachytherapy, cryotherapy, HIFU, or photodynamic therapy; existing image-guidance and planning software assists but the procedure itself remains fully physician-executed.

Provide urology consultation to physicians or other health care professionals.

3

CI 0–6 · exposure 0 · augmentation 50 · importance 4.7/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510011/5Clinical consultation workflows remain highly human-centered with minimal automation. Health systems are far from deploying autonomous AI to replace or provide peer-to-peer consultations, and regulatory, liability, and professional norms strongly discourage such replacement.
Sector adoption velocityclaude-sonnet-52/5Healthcare, especially specialist medicine, adopts AI cautiously due to liability and regulatory concerns, with pilots for documentation/triage but not consultation itself.
Augmentation potentialclaude-haiku-4-5-202510012/5AI can assist a urologist in preparing for consultation (literature retrieval, case summaries, differential generation) but offers limited augmentation for the core consultation act itself, which depends on real-time interaction, judgment, and professional credibility.
Augmentation potentialclaude-sonnet-54/5AI can meaningfully assist urologists by summarizing literature, flagging relevant guidelines, or drafting consult notes, improving efficiency while the specialist retains ultimate judgment.
Task automatabilityclaude-haiku-4-5-202510011/5This task requires specialized medical judgment, peer-to-peer communication, and contextual understanding of complex patient cases that current AI cannot reliably perform end-to-end. AI cannot independently conduct the differential reasoning, synthesize multiple clinical variables, or engage in real-time professional consultation with the nuance required.
Task automatabilityclaude-sonnet-51/5Providing specialist consultation requires synthesizing patient-specific clinical judgment, physical exam findings, and liability for recommendations that AI cannot autonomously perform end-to-end today.
Adoption barriersclaude-haiku-4-5-202510015/5Strong regulatory and legal barriers exist: only licensed physicians can provide medical consultations, malpractice liability attaches to the consulted specialist, and standard of care requires human professional judgment. Peer consultation inherently requires a licensed, credentialed provider.
Adoption barriersclaude-sonnet-55/5Medical consultation between licensed professionals is tightly regulated, requires licensure and malpractice accountability, making AI substitution legally infeasible for the core act.
Cost vs. human wageclaude-haiku-4-5-202510011/5A urologist consultation involves significant human expertise, credentialing, and liability. The cost of deploying AI oversight, validation, and integration into clinical workflows would not be cheaper than having a qualified urologist provide the consultation, especially given regulatory and malpractice risk.
Cost vs. human wageclaude-sonnet-52/5While AI query costs are low, the actual consultation still requires a licensed urologist's review and liability coverage, so realized savings versus full human consultation are minimal.
Technical feasibility todayclaude-haiku-4-5-202510011/5No deployed AI product reliably provides urology consultation to other physicians in production clinical settings. While AI tools can assist with information retrieval or decision support, they do not independently deliver professional-grade consultations that would be trusted by another health care provider.
Technical feasibility todayclaude-sonnet-51/5No deployed product independently provides urology consultations to other physicians in production; AI tools are at most decision-support aids used under physician oversight.

Treat lower urinary tract dysfunctions using equipment such as diathermy machines, catheters, cystoscopes, or radium emanation tubes.

1

CI 0–3 · exposure 0 · augmentation 38 · importance 4.7/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510011/5Urological procedures remain firmly human-dependent; adoption of autonomous AI for invasive lower urinary tract treatment is negligible because regulatory, legal, and clinical safety requirements prevent any meaningful displacement.
Sector adoption velocityclaude-sonnet-52/5Healthcare adoption of AI for diagnostics and documentation is growing, but adoption for actual hands-on invasive procedural treatment remains minimal and slow.
Augmentation potentialclaude-haiku-4-5-202510012/5Imaging AI and diagnostic support tools can assist in pre-procedure planning or post-procedure analysis, but during active catheterization or cystoscopy, the urologist's judgment and manual control dominate; AI's role is limited to passive decision support.
Augmentation potentialclaude-sonnet-53/5AI-assisted imaging, robotic surgical platforms, and diagnostic support can meaningfully aid urologists in planning and guiding these procedures, though the physical execution remains human-led.
Task automatabilityclaude-haiku-4-5-202510011/5This task requires real-time manual dexterity, precise instrument handling through anatomical access points, and immediate clinical decision-making based on visual feedback during an invasive procedure. Current AI cannot operate surgical instruments or catheters independently.
Task automatabilityclaude-sonnet-51/5This is a hands-on invasive medical procedure requiring physical manipulation of instruments inside a patient's body; no AI system can perform physical surgery or catheterization today.
Adoption barriersclaude-haiku-4-5-202510015/5This task is legally protected—only licensed urologists can perform invasive urological procedures. Patients cannot consent to autonomous AI performing catheterization or cystoscopy, and malpractice liability necessitates a credentialed human physician in control.
Adoption barriersclaude-sonnet-55/5Performing invasive procedures requires a licensed physician; strict medical licensing, liability, and legal requirements mandate human-performed surgery and treatment.
Cost vs. human wageclaude-haiku-4-5-202510011/5The cost of acquiring, maintaining, and calibrating specialized urological surgical equipment, combined with required oversight and liability, far exceeds the loaded hourly cost of a trained urologist for this invasive clinical procedure.
Cost vs. human wageclaude-sonnet-51/5AI cannot substitute for the physical procedure itself, so there is no comparable AI cost pathway; human physician cost remains the only option.
Technical feasibility todayclaude-haiku-4-5-202510011/5No deployed AI system can autonomously perform cystoscopic procedures or manage lower urinary tract treatment with catheters and diathermy equipment. Surgical robotics exist but require continuous human control and are not autonomous agents.
Technical feasibility todayclaude-sonnet-51/5No deployed product performs invasive urologic procedures autonomously; robotic surgery systems exist but require a human surgeon operating them, not independent AI execution.

Direct the work of nurses, residents, or other staff to provide patient care.

0

CI 0–0 · exposure 0 · augmentation 25 · importance 4.6/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510011/5Healthcare organizations have not adopted AI to direct clinical staff because legal and regulatory requirements mandate human physician leadership. No sector is moving toward replacing this supervisory function.
Sector adoption velocityclaude-sonnet-51/5Healthcare direct patient-care supervision remains a low-digitization, high-touch domain with essentially no AI adoption in this specific managerial function.
Augmentation potentialclaude-haiku-4-5-202510012/5Scheduling and task-allocation tools can assist with workflow logistics, but AI does not augment the core supervisory judgment, accountability, or authority that defines this task.
Augmentation potentialclaude-sonnet-52/5AI can assist with documentation, scheduling reminders, or care coordination logistics, but offers minimal assistance to the core act of directing and supervising clinical staff in real time.
Task automatabilityclaude-haiku-4-5-202510011/5Directing staff and providing patient care requires real-time judgment, interpersonal authority, accountability for team outcomes, and contextual decision-making that current AI cannot perform end-to-end. No AI system can meaningfully replace a physician's supervisory and clinical responsibility.
Task automatabilityclaude-sonnet-51/5Directing clinical staff requires real-time judgment, authority, and interpersonal leadership in dynamic care settings, which current AI cannot perform end-to-end. No meaningful portion of this supervisory task can be automated today.
Adoption barriersclaude-haiku-4-5-202510015/5Strong legal and professional barriers: state medical boards require a licensed physician to direct patient care and supervise clinical staff. Liability, licensure, and the requirement for human accountability create hard regulatory constraints.
Adoption barriersclaude-sonnet-55/5Directing medical staff care requires licensed physician authority, legal accountability, and clinical supervision responsibilities that cannot be delegated to non-licensed entities, let alone software.
Cost vs. human wageclaude-haiku-4-5-202510011/5AI oversight and decision-support systems would require substantial infrastructure, licensing, validation, and human oversight—likely exceeding the cost of a physician performing the task directly.
Cost vs. human wageclaude-sonnet-51/5There is no AI system performing this managerial/clinical leadership function, so no viable cost comparison exists; the human physician is the only option.
Technical feasibility todayclaude-haiku-4-5-202510011/5No deployed product reliably directs clinical staff, manages hierarchies, delegates tasks, or assumes accountability for patient outcomes. This remains a fundamentally human supervisory and leadership function.
Technical feasibility todayclaude-sonnet-51/5No deployed product directs nurses, residents, or clinical staff in patient care; this remains firmly a human leadership function with no AI substitute in production.

Related occupations — Healthcare Practitioners & Technical

How to read this

A high substitution score does not mean this job disappears — it means a large share of its current tasks face replacement pressure, so the mix of tasks is likely to change. High augmentation alongside substitution typically means the occupation reorganizes around the protected tasks. Wide confidence intervals mean the rater panel disagreed: treat those scores as open questions, not verdicts.

What would change this score

New model capabilities (automatability, feasibility), falling inference costs (cost ratio), regulation and licensing shifts (barriers), and measured sector adoption (velocity) all re-enter at every index release. Each release is recomputed, versioned and kept queryable — scores are claims with a date on them, not permanent labels.